You have read all your free articles, to continue reading subscribe to read the rest of this content.
The company is expecting to communicate results from a recently concluded Phase 2 trial of its drug candidate Rabeximod in COVID-19 patients during the fourth quarter. The results were previously slated for the third quarter. The postponement is due to the company’s decision to leverage the U.SAlready a subscriber Login…
On 27 May the European Commission presented in Parliament a €750 billion economic stimulus plan that along with a revised proposal for the EU's 2021-2027 budget should help mitigate the shock from the coronavirus pandemic and pave the way for a sustainable future. Commission President Ursula von Already a subscriber…
In a new study published in JAMA researchers at Karolinska Institutet and Karolinska University Hospital have examined the association between a positive SARS-CoV-2 test during pregnancy and complications in mothers and their newborn babies. Almost two out of three pregnant women who tested positAlready a subscriber Login You have read…
The Ministry of Healthcare of Republic of Azerbaijan granted an approval to conduct clinical trials of the combined use of the Sputnik V and the COVID 19 vaccine AstraZeneca in Azerbaijan. Previously, the Gamaleya National Center, RDIF, AstraZeneca and R-Pharm signed an agreement to cooperate Already a subscriber Login You have read all…
